BCL2L11 and pancreatic neoplasm: Wu et al [36] found COMT overexpression to cause enhanced apoptosis of gemcitabine-treated pancreatic cancer cells and this was due to enhanced levels of pro-apoptotic Bim and Bax, but reduced anti-apoptotic p-Bad.